Cargando…

Induced pluripotent stem cells (iPS) derived disease models: In vivo to in vitro gaps

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Journal of Stem Cells and Regenerative Medicine 2018
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339977/ https://www.ncbi.nlm.nih.gov/pubmed/30679889

Ejemplares similares

Generation of Induced Pluripotent Stem (iPS) Cells by Nuclear Reprogramming
por: Dey, Dilip, et al.
Publicado: (2011)

Induced pluripotent stem (iPS) cells: an up-to-the-minute review
por: Lau, Frank, et al.
Publicado: (2009)

Induced Pluripotent Stem (iPS) Cells in Dentistry: A Review
por: Malhotra, Neeraj
Publicado: (2016)

Beyond iPS!
Publicado: (2012)

Aging in iPS cells
por: Miller, Justine, et al.
Publicado: (2014)

A protocol for metabolic characterization of human induced pluripotent stem cell-derived cardiomyocytes (iPS-CM)
por: House, Alisha, et al.
Publicado: (2019)

An iPS‐derived in vitro model of human atrial conduction
por: Biendarra‐Tiegs, Sherri M., et al.
Publicado: (2022)

Evolving science enhanced with iPS
Publicado: (2007)

Modulation of Pluripotency in the Porcine Embryo and iPS Cells
por: Rodríguez, Aida, et al.
Publicado: (2012)

iPS-Cinderella Story in Cell Biology
Publicado: (2010)

Editorial for Special Issue: iPS Cells (iPSCs) for Modelling and Treatment of Human Diseases
por: Graffmann, Nina, et al.
Publicado: (2022)

Induced pluripotent stem (iPS) cells offer a powerful new tool for the life sciences
por: Nakamura, Y
Publicado: (2010)

Highly Effective Protocol for Differentiation of Induced Pluripotent Stem Cells (iPS) into Melanin-Producing Cells
por: Sułkowski, Maciej, et al.
Publicado: (2021)

Metformin limits the tumourigenicity of iPS cells without affecting their pluripotency
por: Vazquez-Martin, Alejandro, et al.
Publicado: (2012)

Profiling the microRNA Expression in Human iPS and iPS-derived Retinal Pigment Epithelium
por: Wang, Heuy-Ching, et al.
Publicado: (2014)

Modeling Kidney Disease with iPS Cells
por: Freedman, Benjamin S.
Publicado: (2015)

A Systematic Evaluation of Integration Free Reprogramming Methods for Deriving Clinically Relevant Patient Specific Induced Pluripotent Stem (iPS) Cells
por: Goh, Pollyanna A., et al.
Publicado: (2013)

Retinal Pigment Epithelial Cells Derived from Induced Pluripotent Stem (iPS) Cells Suppress or Activate T Cells via Costimulatory Signals
por: Sugita, Sunao, et al.
Publicado: (2020)

Generation of Human Induced Pluripotent Stem (iPS) Cells in Serum- and Feeder-Free Defined Culture and TGF-β1 Regulation of Pluripotency
por: Yamasaki, Sachiko, et al.
Publicado: (2014)

The Promise and Therapeutic Potential of Human ES and iPS Cells
por: Lu, Shi-Jiang, et al.
Publicado: (2011)

The novel application of cordycepin in maintaining stem cell pluripotency and increasing iPS cell generation efficiency
por: Wang, Chie-Hong, et al.
Publicado: (2020)

The tumourigenicity of iPS cells and their differentiated derivates
por: Liu, Zhiqiang, et al.
Publicado: (2013)

iPS‐derived pericytes for neurovascular regeneration
por: Kirabali, Tunahan, et al.
Publicado: (2021)

An ES-Like Pluripotent State in FGF-Dependent Murine iPS cells
por: Di Stefano, Bruno, et al.
Publicado: (2010)

Correction: Generation of Human Induced Pluripotent Stem (iPS) Cells in Serum- and Feeder-Free Defined Culture and TGF-β1 Regulation of Pluripotency
Publicado: (2014)

Mind the gap: leak currents and induced pluripotent stem cell–derived cardiomyocytes in translational cardiac electrophysiology
por: Heijman, Jordi, et al.
Publicado: (2023)

Modeling SHH-driven medulloblastoma with patient iPS cell-derived neural stem cells
por: Susanto, Evelyn, et al.
Publicado: (2020)

Animal Disease Models and Patient-iPS-Cell-Derived In Vitro Disease Models for Cardiovascular Biology—How Close to Disease?
por: Kawaguchi, Nanako, et al.
Publicado: (2023)

Biallelic correction of sickle cell disease‐derived induced pluripotent stem cells (iPSCs) confirmed at the protein level through serum‐free iPS‐sac/erythroid differentiation
por: Haro‐Mora, Juan J., et al.
Publicado: (2020)

Cell Therapy Using Induced Pluripotent Stem (iPS) Cells Meets Next-Next Generation DNA Sequencing Technology
por: Nakayama, Manabu
Publicado: (2009)

Human iPS cell-derived mural cells as an in vitro model of hereditary cerebral small vessel disease
por: Yamamoto, Yumi, et al.
Publicado: (2020)

iPS Cells for Modelling and Treatment of Retinal Diseases
por: Chen, Fred K., et al.
Publicado: (2014)

Acetylation-dependent regulation of essential iPS-inducing factors: a regulatory crossroad for pluripotency and tumorigenesis
por: Dai, Xiangpeng, et al.
Publicado: (2014)

Lineage conversion induced by pluripotency factors involves transient passage through an iPS cell stage
por: Bar-Nur, Ori, et al.
Publicado: (2015)

The Exciting Realities and Possibilities of iPS-Derived Cardiomyocytes
por: Takahashi, Fuga, et al.
Publicado: (2023)

Maxadilan Prevents Apoptosis in iPS Cells and Shows No Effects on the Pluripotent State or Karyotype
por: Zhao, Zhiyi, et al.
Publicado: (2012)

DNA repair and replication links to pluripotency and differentiation capacity of pig iPS cells
por: Liu, Kai, et al.
Publicado: (2017)

Protocol for the derivation, culturing, and differentiation of human iPS-cell-derived neuroepithelial stem cells to study neural differentiation in vitro
por: Calvo-Garrido, Javier, et al.
Publicado: (2021)

Ethanol-mediated activation of the NLRP3 inflammasome in iPS cells and iPS cells-derived neural progenitor cells
por: De Filippis, Lidia, et al.
Publicado: (2016)

The SIRT6 activator MDL‐800 improves genomic stability and pluripotency of old murine‐derived iPS cells
por: Chen, Yu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_i35cv8maa5lfbl3fcvb7sb16ui